| Mrs Juliane Schmoll, MS, CCC-SLP | |
|
10 E. Washington Ave, Atlantic Highlands, NJ 07716-1227 | |
| (646) 319-2611 | |
| Not Available |
| Full Name | Mrs Juliane Schmoll |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 10 E. Washington Ave, Atlantic Highlands, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700047529 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 012089 (New York) | Secondary |
| 235Z00000X | Speech-language Pathologist | 41YS00561700 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Juliane Schmoll, MS, CCC-SLP 10 E. Washington Ave, Atlantic Highlands, NJ 07716-1227 Ph: (646) 319-2611 | Mrs Juliane Schmoll, MS, CCC-SLP 10 E. Washington Ave, Atlantic Highlands, NJ 07716-1227 Ph: (646) 319-2611 |
News Archive
This week, I responded to readers who were unhappy with their health plan's decision not to pay an emergency department surcharge for after-hours care and concerned about difficulties getting Medicare to cover claims unrelated to a workers' compensation injury.
Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.
The University of Glasgow has linked up with venture capital company Fifty-Six Ltd. to launch Crucial Genetics, a state-of-the-art genetic profiling service. The company is based within customised laboratory facilities at the Southern General Hospital, Glasgow and is equipped with the latest automated fluorescent DNA laser scanning machinery.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it has leased laboratory space (the "NanoShrink Lab") inside the TechPortal, an innovative and brand new technology facilitator center for commercial bioscience research companies which are in most cases based on University of California, Irvine research.
› Verified 9 days ago
Salina Marie Scullin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1041 Route 36, Atlantic Highlands, NJ 07716 Phone: 732-788-3502 | |
Eva Huber, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Cottage Gate, Atlantic Highlands, NJ 07716 Phone: 732-737-7790 Fax: 732-291-1578 | |
Mrs. Toni-marie Marino, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 252 1000 Oaks Dr, Atlantic Highlands, NJ 07716 Phone: 732-690-0935 | |
Alyssa Plancey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1041 Route 36, Atlantic Highlands, NJ 07716 Phone: 732-788-3502 |